EUROPEAN SELECTED SECTORS, FI

Enters the portfolio at 7.15% weight.

Enters the portfolio at 4.15% weight.

Enters the portfolio at 4.05% weight.

Enters the portfolio at 3.97% weight.

Airbus SE, together with its subsidiaries, engages in the design, manufacture, and delivery of aeronautics and aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet passenger aircraft, freighter aircraft, regional turboprop aircraft, and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment develops, manufactures, markets, and sells civil and military helicopters; and provides uncrewed aerial systems and their related services. The Airbus Defence and Space segment designs, develops, delivers, and supports crewed and uncrewed military air systems and related services. This segment also offers civil and defence space systems for telecommunications, earth observations, navigation, and science and orbital systems; and services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. The company was incorporated in 1998 and is headquartered in Leiden, the Netherlands.

Enters the portfolio at 3.91% weight.

Enters the portfolio at 3.85% weight.

Enters the portfolio at 3.73% weight.

Enters the portfolio at 3.65% weight.

Enters the portfolio at 3.39% weight.

Enters the portfolio at 3.39% weight.

Enters the portfolio at 3.36% weight.

Sopra Steria Group SA provides consulting, digital, and software development services in France and internationally. The company offers digital transformation consulting services; artificial intelligence; technology services in the field of artificial intelligence, blockchain, cloud, data, internet of things, digital interactions, emerging technologies, 5G design center, industrial metaverse, and intelligent process automation; systems integration comprising smart application modernization and product lifecycle management; infrastructure management services, including consulting, cloud, end-user support, digital workplace, and legacy services; and cybersecurity services. It also provides software solution, such as HR solutions and innovations, and property management solutions; and information warfare solutions. In addition, the company offers business process services, such as creation or on-boarding, and operation of multi-function shared services; and operation of finance and administration, and human resource functions, as well as operation of specialized industry-specific business processes comprising operating and executing services in police control rooms, managing compliance in financial services, and managing customer services for large utilities. It serves aerospace, defense and security, energy and utilities, financial services, insurance and social, government, retail, telecommunication, media and entertainment, space, and transport industries. The company was formerly known as Sopra Group and changed its name to Sopra Steria Group SA in September 2014. Sopra Steria Group SA was incorporated in 1968 and is headquartered in Paris, France.

Enters the portfolio at 3.34% weight.

Enters the portfolio at 3.21% weight.

Enters the portfolio at 2.99% weight.

Enters the portfolio at 2.89% weight.

Enters the portfolio at 2.82% weight.

Enters the portfolio at 2.54% weight.

Enters the portfolio at 2.52% weight.

Alten S.A. operates as an engineering and technology consultancy company in France, North America, Germany, Scandinavia, Benelux, Iberian, Italy, the United Kingdom, the Asia-Pacific, Switzerland, Eastern Europe, and internationally. It undertakes projects for the technical, research and development, and information systems divisions of industrial, telecoms, and service clients. The company also provides engineering services, such as mechanic and materials, data management, systems engineering and PDM, project management office, quality assurance, manufacturing, environment, health and safety, electronics; embedded software; and construction infrastructure services. In addition, it provides IT services comprising AMOA and business analyst; cybersecurity; artificial intelligence; application software; data management; green IT; software testing and QA; and cloud and infrastructure services. The company serves customers in aeronautics, space, defense and naval, security, automotive, rail and mobility, energy and environment, life sciences and health, banking, industrial equipment and electronics, banking, finance and insurance, telecoms, retail, services, media, and public sectors and government services. Alten S.A. was incorporated in 1988 and is headquartered in Boulogne-Billancourt, France.

Enters the portfolio at 2.34% weight.

Enters the portfolio at 2.31% weight.

Stellantis N.V. engages in the designing, engineering, manufacturing, distribution, and sale of automobiles and light commercial vehicles, engines, transmission systems, and mobility services worldwide. It provides luxury and premium vehicles; sport utility vehicles; and parts and accessories. The company also provides contract services; retail and dealer financing services; and vehicle leasing and rental services, as well as engages in after-market parts and service businesses and data businesses. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, DS Automobiles, Dodge, Fiat, Jeep, Maserati, Ram Trucks, Opel, Lancia, Vauxhall, Peugeot, Free2move, Share Now, Leasys, and Comau brand names through distributors and dealers. The company has a strategic collaboration with Microsoft Corporation for the development of AI initiatives across sales, customer care, and operations. The company operates in North America, France, Brazil, Italy, Germany, the United Kingdom, Turkiye, Spain, Argentina, Belgium, Austria, the Netherlands, Portugal, Poland, Algeria, Morocco, Japan, China, and internationally. Stellantis N.V. was founded in 1899 and is based in Hoofddorp, the Netherlands.

Enters the portfolio at 2.24% weight.

Enters the portfolio at 2.21% weight.

Enters the portfolio at 2.09% weight.

Enters the portfolio at 2.08% weight.

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Enters the portfolio at 2.00% weight.

Enters the portfolio at 2.00% weight.

Enters the portfolio at 1.94% weight.

K+S Aktiengesellschaft, together with its subsidiaries, operates as a supplier of mineral products for the agricultural, industrial, pharma, consumer, and community sectors in Europe, Germany, North America, South America, Asia, Africa, and Oceania. The company offers potassium chloride for crops, such as grain, corn, rice, soybeans, and sugar cane; fertilizer specialties that are used for crops with magnesium and sulfur requirements, including rapeseed, sugar beet, and potatoes, as well as for chloride-sensitive specialty crops such as citrus, grapes, coffee, almond trees, and vegetables; and water-soluble fertilizers for use in fertigation of fruit and vegetables under the KALISOP, KORN-KALI, ROLLKALI, PATENTKALI, ESTA KIESERIT, GRANUAID, MAGNESIA-KAINIT, SOLUMOP, SOLUSOP, SOLUCMS, EPSO TOP, EPSO MICROTOP, EPSO COMBITOP, EPSO PROFITOP, and EPSO BORTOP brands. It also provides soil, fertigation, foliar fertilizers, natural rock salt, high-purity vaccum salt and mineral salt mixtures, potassium chloride, potassium sulphate, Epsom salt, minerals for pets and livestock, potassium, magnesium, salt, salt licks for farm and wild animals, sodium chloride, salt tablets, and vacuum salt granules under the k-DRILL, KaSa, SOLSEL, NUTRIKS, AXAL PRO, REGINET, Regesal, Marina, Marina Plus, Solea, and APISAL brands. In addition, the company offers salts under the Cérébos brand; rock salt under the Solné mlýny Olomouc brand; sea salt under the Vatel and Salinas d'Algarve brands; Saltissimo brands; optimal solutions for their homes under the AXAL Pro and AXAL brand; rock and pink salts under the Saldoro brand; dishwasher salt under the Regesoft brand; and Coarse rock salt under the DI-MIX brand. Further, the company provides waste management; and transportation and logistics services. Aktiengesellschaft was founded in 1889 and is headquartered in Kassel, Germany.

Enters the portfolio at 1.72% weight.

Enters the portfolio at 1.65% weight.

Enters the portfolio at 1.61% weight.

Enters the portfolio at 1.59% weight.

Enters the portfolio at 1.46% weight.

Enters the portfolio at 1.42% weight.

Enters the portfolio at 1.38% weight.

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Enters the portfolio at 1.21% weight.